Eolo Pharma

Wilmington, United States

Eolo Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases.

$1.8M raised

Feb 2023

Venture - Series Unknown

Top Investors

Ficus CapitalCites

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Eolo Pharma raised?

Eolo Pharma has raised $1.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2023.

Who are Eolo Pharma's investors?

Eolo Pharma's investors include Ficus Capital, Cites.

Where is Eolo Pharma headquartered?

Eolo Pharma is headquartered in Wilmington, United States.

What does Eolo Pharma do?

Eolo Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases.

What stage is Eolo Pharma at?

Eolo Pharma is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 8, 2023.

MLA

"Eolo Pharma — Funding & Investors." VCBacked, February 8, 2023, https://www.vcbacked.co/company/eolo-pharma. Accessed June 9, 2026.

APA

VCBacked. (2023). Eolo Pharma — Funding & Investors. Retrieved June 9, 2026, from https://www.vcbacked.co/company/eolo-pharma

Wikipedia (cite web)

{{cite web |title=Eolo Pharma — Funding & Investors |url=https://www.vcbacked.co/company/eolo-pharma |website=VCBacked |access-date=June 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 8, 2023.